The evolution of tear substitutes: from saline solutions to cationic nanoemulsion

Cover Page


The article defines the milestones of the development of the main types of artificial tears, describes characteristics and benefits of the new tear substitute Cationorm® based on Novasorb® technology: electrostatic mucoadhesion, rapid and optimal spreading, and long time of contact with the ocular surface, favorable action on all tear film layers, osmoregulation, compatibility with different contact lens types, and prolonged clinical efficacy.

Aleksander Vladimirovich Vokhmyakov

Santen Oy Representation in Moscow

MD, ophthalmologist, Scientific Adviser

  • Бржеский В. В., Астахов Ю. С., Кузнецова Н. Ю. Заболевания слёзного аппарата: пособие для практикующих врачей. 2-е изд., испр. и доп. СПб.: Изд-во Н-Л; 2009.
  • Бржеский В. В. Синдром «сухого глаза» при дисфункции мейбомиевых желез. Российская офтальмология онлайн. 2013; № 11, электронное издание. Доступен по: (дата обращения 26.12.2013).
  • Вохмяков А. В. Нанотехнологии в офтальмологии: шаг вперёд в коррекции патологии поверхности глаз. В кн.: Офтальмология. Восточная Европа. - Спецвыпуск: Материалы республ. науч. конф. с междунар. участием «Современная реконструктивная хирургия в офтальмологии». Минск; 2013: 29-32.
  • report of the international dry eye workshop (DEWS). Ocul Surf. 2007; 5 (2): 65-204.
  • Amrane M., Buggage R., Ismail D., Garrigue J. S., Deniaud M., Baudouin C. Efficacy of Cationorm® Preservativefree Cationic Emulsion versus Refresh® in Dry Eye Disease (DED) Patients With/Without Meibomian Gland Dysfunction (MGD). In: Program and abstract book. Poster P-16 at the 1st Conference on the Tear Film and Ocular Surface in Asia. 2012: 39
  • Baudouin C. A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol. 2007; 30 (3): 239-46.
  • Daull P., Lallemand F., Garrigue J. S. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol. 2013; 26. doi: 10.1111/jphp.12075.
  • Determination of physical compatibility of Cationorm® with contact lenses. Data on file. Final report ID 08-17, 16 April 2008. Addendum ID 08-23, 25 April 2008.
  • Ismail D., Amrane M., Creuzot C., Pisella P. J., Buggage R. R., Baudouin C. Evaluation of ocular tolerance and exploration of the efficacy of Cationorm® unpreserved eye drops versus Refresh® in patients with mild to moderate dry eye syndrome. Eur J Ophthalmol 2011; doi: 10.5301/EJO.2011.7695.
  • Lemp M. A., Bron A. J., Baudouin C., Benítez Del Castillo J. M., Geffen D., Tauber J., Foulks G. N., Pepose J. S., Sullivan B. D. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011; 151 (5): 792-798.e1. doi: 10.1016/j.ajo.2010.10.032.
  • Lemp M. A., Crews L. A., Bron A. J., Foulks G. N., Sullivan B. D. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012; 31 (5): 472-8. doi: 10.1097/ICO.0b013e318225415a.
  • Lallemand F., Daull P., Benita S., Buggage R., Garrigue J. S. Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb. J Drug Deliv. 2012; 2012: 604204. doi: 10.1155/2012/604204.
  • Nichols K. K., Foulks G. N., Bron A. J., Glasgow B. J., Dogru M., Tsubota K., Lemp M. A., Sullivan D. A. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011; 52 (4): 1922-9. doi: 10.1167/iovs.10-6997a.
  • van Bijsterveld O. P. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969; 82 (1): 10-4.


Abstract - 1519

PDF (Russian) - 561


Copyright (c) 2014 Vokhmyakov A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.